Back to search
Infarction, Brain
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Infarction, Brain trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Infarction, Brain trials you may qualify forBackground: Stroke is the fifth leading cause of death in the United States. It is also a leading cause of disability. More than 70% of people who survive stro…
The primary objective of this study is to further define the mechanisms of action of Mexidol® (solution for intravenous and intramuscular injection, 50 mg/ml) a…
This open-label extension study will provide post-trial access to pelacarsen (TQJ230) to participants who have successfully completed the double-blind parent st…
DAN-ZOSTER is a nationwide randomized study investigating whether vaccination against herpes zoster (shingles) can reduce the risk of cardiovascular disease and…
The goal of this clinical trial is to determine if Transcranial Magnetic Stimulation (TMS) combined with modified Constraint Induced Language Therapy (mCILT) is…
In modern medicine, doctors attempt to monitor all physiological variables to assess their evolution and to decide, based on their changes, the therapeutic atti…
This study evaluates whether early administration of low-dose aspirin (100mg) at 2 hours post-intravenous thrombolysis, compared to the standard timing of 24 ho…
This is a pivotal phase 3 study designed to support an indication for the reduction of cardiovascular risk in patients with established CVD and elevated Lp(a)